Dendritic cell sarcoma not otherwise specified

Last reviewed March 21, 2026

🖨 Print for my doctor Advocacy Hub →

ORPHA:86903C96.4

Who is this for?

Show terms as

20Specialists 8Treatment centers

Where are you in your journey?

ℹ

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.

Report missing data

Overview

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events

May 2026Long-term Study to Evaluate Safety and Persistence of GF-CART01

GenomeFrontier Therapeutics TW Co., Ltd.

TrialNOT YET RECRUITING

Mar 2026Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma

Henan Cancer Hospital

TrialNOT YET RECRUITING

Feb 2026Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCL

The First Affiliated Hospital with Nanjing Medical University — NA

TrialNOT YET RECRUITING

Jan 2026This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

LTZ Therapeutics, Inc. — PHASE1

TrialRECRUITING

Jan 2026Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Li Zhiming — PHASE2

TrialNOT YET RECRUITING

Dec 2025DALY II Japan/MB-CART2019.1 for DLBCL

Miltenyi Biomedicine GmbH — PHASE2

TrialRECRUITING

Nov 2025Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL

The First Affiliated Hospital of Soochow University — PHASE2

TrialRECRUITING

Oct 2025ImmunoMRI for Assessment of Tumor-associated Macrophages

Medical University of Vienna — EARLY_PHASE1

TrialNOT YET RECRUITING

Feb 2025AZA Combined with R-GemOx for Elderly DLBCL Patients

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University — PHASE2

TrialNOT YET RECRUITING

Aug 2024Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes

The First Affiliated Hospital with Nanjing Medical University — PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Dendritic cell sarcoma not otherwise specified.

View clinical trials →

Clinical Trials

View all trials with filters →

No actively recruiting trials found for Dendritic cell sarcoma not otherwise specified at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Dendritic cell sarcoma not otherwise specified community →

Specialists

20 foundView all specialists →

DM

David Maloney

Specialist

Acute lymphoblastic leukemia Acute mast cell leukemia Acute myeloid leukemia+65 more

PI on 11 active trials

Active trials Directions Travel grants

PM

Pier Luigi Zinzani, MD

Specialist

Autoimmune lymphoproliferative syndrome Castleman disease Classic hairy cell leukemia+2 more

PI on 5 active trials

Active trials Directions Travel grants

EM

Eric Jacobsen, MD

Specialist

Angioimmunoblastic T-cell lymphoma Erdheim-Chester disease Langerhans cell sarcoma+1 more

PI on 4 active trials

Active trials Directions Travel grants

CD

Colleen Delaney

OLD GREENWICH, CT

Specialist

Acute erythroid leukemia Acute megakaryoblastic leukemia Acute megakaryoblastic leukemia in adult+25 more

PI on 3 active trials

Active trials Directions Travel grants

JM

Jennifer Lue, MD

NEW YORK, NY

Specialist

Aggressive B-cell non-Hodgkin lymphoma Histiocytic and dendritic cell tumor Histiocytic sarcoma+2 more

PI on 1 active trial

Active trials Directions Travel grants

AF

Andrea T Franson

ANN ARBOR, MI

Specialist

Atypical teratoid rhabdoid tumor Embryonal rhabdomyosarcoma Ependymoma+17 more

PI on 1 active trial

Active trials Directions Travel grants

PM

Paul Martin

Specialist

Acute myelomonocytic leukemia Bone sarcoma Burkitt lymphoma+63 more

PI on 3 active trials73 Dendritic cell sarcoma not otherwise specified publications

Active trials Directions Travel grants

SM

Susan K. Parsons, MD, MRP

Specialist

Acute myelomonocytic leukemia Atypical chronic myeloid leukemia Bone sarcoma+28 more

PI on 1 active trial

Active trials Directions Travel grants

NM

Nirali N Shah, M.D.

Specialist

Acute lymphoblastic leukemia Adult T-cell leukemia/lymphoma Burkitt lymphoma+14 more

PI on 7 active trials

Active trials Directions Travel grants

KP

Kelly McConnell, PhD

Specialist

B-cell non-Hodgkin lymphoma Colobomatous microphthalmia Dendritic cell tumor+7 more

PI on 2 active trials

Active trials Directions Travel grants

KM

Kenneth G. Lucas, MD

Specialist

Acute mast cell leukemia Acute myeloid leukemia with 11q23 abnormalities Acute myeloid leukemia with recurrent genetic anomaly+40 more

PI on 7 active trials

Active trials Directions Travel grants

DP

Don Diamond, PhD

Specialist

Atypical chronic myeloid leukemia Chronic eosinophilic leukemia Chronic myeloproliferative disease, unclassifiable+16 more

PI on 1 active trial

Active trials Directions Travel grants

AW

Ann Woolfrey

SEATTLE, WA

Specialist

Acute mast cell leukemia Acute radiation syndrome Adult T-cell leukemia/lymphoma+66 more

PI on 5 active trials

Active trials Directions Travel grants

KM

Kenneth Cooke, MD

BALTIMORE, MD

Specialist

Acquired idiopathic sideroblastic anemia Acute myeloid leukemia with 11q23 abnormalities Atypical chronic myeloid leukemia+12 more

PI on 1 active trial

Active trials Directions Travel grants

FD

Felix Keil, Prim. Univ. Prof. Dr

Specialist

Dendritic cell tumor Follicular dendritic cell sarcoma Histiocytic and dendritic cell tumor+2 more

PI on 1 active trial

Active trials Directions Travel grants

MM

Minoti Hiremath, MD

Specialist

Adult T-cell leukemia/lymphoma Aggressive NK-cell leukemia Burkitt lymphoma+19 more

PI on 2 active trials

Active trials Directions Travel grants

FF

Francois Bénard, MD, FRCPC

Specialist

Dendritic cell tumor Histiocytic and dendritic cell tumor Histiocytic sarcoma

PI on 1 active trial

Active trials Directions Travel grants

EF

Eric Turcotte, MD, FRCPC

Specialist

Dendritic cell tumor Histiocytic and dendritic cell tumor Histiocytic sarcoma

PI on 1 active trial

Active trials Directions Travel grants

VM

Virginie Bruneau, MD

Specialist

Dendritic cell tumor Histiocytic and dendritic cell tumor Histiocytic sarcoma

PI on 1 active trial

Active trials Directions Travel grants

AP

Ana Patiño-García

Specialist

PI on 1 active trial

Active trials Directions Travel grants

Treatment Centers

8 centers

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Dendritic cell sarcoma not otherwise specified.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Dendritic cell sarcoma not otherwise specifiedForum →

No community posts yet. Be the first to share your experience with Dendritic cell sarcoma not otherwise specified.

Start the conversation →

Latest news about Dendritic cell sarcoma not otherwise specified

Disease timeline:

New recruiting trial: A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.

A new clinical trial is recruiting patients for Dendritic cell sarcoma not otherwise specified

New recruiting trial: Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL

A new clinical trial is recruiting patients for Dendritic cell sarcoma not otherwise specified

New recruiting trial: Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

A new clinical trial is recruiting patients for Dendritic cell sarcoma not otherwise specified

New recruiting trial: Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

A new clinical trial is recruiting patients for Dendritic cell sarcoma not otherwise specified

New recruiting trial: Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta

A new clinical trial is recruiting patients for Dendritic cell sarcoma not otherwise specified

New recruiting trial: P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

A new clinical trial is recruiting patients for Dendritic cell sarcoma not otherwise specified

New recruiting trial: Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)

A new clinical trial is recruiting patients for Dendritic cell sarcoma not otherwise specified

New recruiting trial: AZA Combined With RCHOP in P53-mutated DLBCL.

A new clinical trial is recruiting patients for Dendritic cell sarcoma not otherwise specified

New recruiting trial: Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

A new clinical trial is recruiting patients for Dendritic cell sarcoma not otherwise specified

New recruiting trial: Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL

A new clinical trial is recruiting patients for Dendritic cell sarcoma not otherwise specified

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Dendritic cell sarcoma not otherwise specified

Which specialists treat Dendritic cell sarcoma not otherwise specified?

20 specialists and care centers treating Dendritic cell sarcoma not otherwise specified are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.